Subscribe / Unsubscribe Enewsletters | Login | Register

Pencil Banner

MIT uses nanotech to hit cancer with one-two punch

Sharon Gaudin | May 12, 2014
In a second report this week on scientists' use of nanotechnology to battle cancer, researchers at MIT announced a new way to use nanoparticles to give cancerous cells a one-two punch.

The treatment has been tested on triple-negative breast tumors, along with non-small-cell lung tumors. Both types of cancers were shrunk significantly, according to MIT.

Earlier this week, researchers at Johns Hopkins University reported that they have used nanoparticles as Trojan horses that deliver "death genes" to kill brain cancer cells beyond the reach of surgeons.

This particular nano-based treatment, which focused on glioblastomas, the most lethal and aggressive form of brain cancer, uses biodegradable nanoparticles that deliver genes that induce death in cancer cells but don't affect healthy cells.

The Johns Hopkins treatment has been tested on mice but not on humans.

 

Previous Page  1  2 

Sign up for CIO Asia eNewsletters.